These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Cardillo G; Facciolo F; Carbone L; Regal M; Corzani F; Ricci A; Di Martino M; Martelli M Eur J Cardiothorac Surg; 2002 Feb; 21(2):302-5; discussion 305-6. PubMed ID: 11825740 [TBL] [Abstract][Full Text] [Related]
8. Management of malignant pleural effusion secondary to breast cancer: talc pleurodesis and pleuroperitoneal shunting. Saute M Isr J Med Sci; 1995; 31(2-3):160-2. PubMed ID: 7744586 [TBL] [Abstract][Full Text] [Related]
9. The value of small-bore catheter thoracostomy in the treatment of malignant pleural effusions. Sahin U; Unlü M; Akkaya A; Ornek Z Respiration; 2001; 68(5):501-5. PubMed ID: 11694813 [TBL] [Abstract][Full Text] [Related]
11. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions. Ong KC; Indumathi V; Raghuram J; Ong YY Respirology; 2000 Jun; 5(2):99-103. PubMed ID: 10894097 [TBL] [Abstract][Full Text] [Related]
14. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion. Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235 [TBL] [Abstract][Full Text] [Related]
15. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study. Stefani A; Natali P; Casali C; Morandi U Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008 [TBL] [Abstract][Full Text] [Related]
16. Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial. Bhatnagar R; Piotrowska HEG; Laskawiec-Szkonter M; Kahan BC; Luengo-Fernandez R; Pepperell JCT; Evison MD; Holme J; Al-Aloul M; Psallidas I; Lim WS; Blyth KG; Roberts ME; Cox G; Downer NJ; Herre J; Sivasothy P; Menzies D; Munavvar M; Kyi MM; Ahmed L; West AG; Harrison RN; Prudon B; Hettiarachchi G; Chakrabarti B; Kavidasan A; Sutton BP; Zahan-Evans NJ; Quaddy JL; Edey AJ; Clive AO; Walker SP; Little MHR; Mei XW; Harvey JE; Hooper CE; Davies HE; Slade M; Sivier M; Miller RF; Rahman NM; Maskell NA JAMA; 2020 Jan; 323(1):60-69. PubMed ID: 31804680 [TBL] [Abstract][Full Text] [Related]
17. Management of recurrent malignant pleural effusion with chemical pleurodesis. Kilic D; Akay H; Kavukçu S; Kutlay H; Cangir AK; Enön S; Kadilar C Surg Today; 2005; 35(8):634-8. PubMed ID: 16034542 [TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions. Kolschmann S; Ballin A; Gillissen A Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739 [TBL] [Abstract][Full Text] [Related]
19. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. Hartman DL; Gaither JM; Kesler KA; Mylet DM; Brown JW; Mathur PN J Thorac Cardiovasc Surg; 1993 Apr; 105(4):743-7; discussion 747-8. PubMed ID: 7682268 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of malignant pleural effusion by pleurodesis with talc]. Filippetti M; Crucitti G; Vanni B; Della Giulia M; Foggi P; Del Monte G Chir Ital; 2000; 52(5):541-7. PubMed ID: 11190547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]